Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ran guanine nucleotide release factor (RANGRF), also known as MOG1, is a regulatory protein that plays a critical role in promoting guanine nucleotide release from the small GTPase RAN, thereby regulating nuclear transport and mitotic spindle dynamics. RANGRF is essential for the proper cell surface expression and function of the cardiac sodium channel Na(v)1.5 (encoded by SCN5A) in cardiomyocytes and regulates membrane localization of this channel, which is crucial for normal cardiac conduction and rhythm. Mutations in RANGRF have been implicated in cardiac arrhythmias, including Brugada syndrome, by disrupting sodium channel trafficking and impairing cardiac action potential propagation[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ran guanine nucleotide release factor (RANGRF).